ABL1 and neoplasm: Latest research has shown that c-ABL can enhance the anti-tumor action of ERβ by directly controlling the status of phosphotyrosine residue (Y36).17 Therefore, regulation of c-ABL/ERβ signal maybe one potent therapeutic method for PCa.